Company Announcements

announments-bgtopright
announments-bgtopleft

Aceto Acquires Syntor Fine Chemicals

Acquisition strengthens Aceto's Offering of differentiated specialty materials and solutions in life sciences and advanced technology end markets.

Port Washington, NY (USA) - April 17, 2020 - Aceto, a leading virtual manufacturer of specialty materials for life sciences, nutrition, agricultural, and advanced technology end markets and a New Mountain Capital portfolio company, announced its acquisition of Syntor Fine Chemicals today. Syntor is an asset-light manufacturer of fine chemicals for pharmaceutical and other life sciences end markets.

“The acquisition of Syntor is an important step in Aceto’s strategic growth plan,” said Gilles Cottier, Chief Executive Officer of Aceto. “Syntor’s synthesis and formulation capabilities enhance Aceto’s existing services and expand our value-added offerings in life sciences materials. With the addition of Syntor’s technical team, we can provide greater product customization in addition to supplying our current offering of high quality, specialty materials.”

“We are very pleased and excited about our partnership with Aceto,” said Simon Knowles, Managing Partner of Syntor. “The two companies are well aligned in their culture and drive to maximize value to customers through sourcing and development of complex chemistries. We believe Syntor will thrive with the support of Aceto’s global infrastructure and we look forward to contributing to the next stage of growth for the combined company.”

Andre Moura, a Managing Director at New Mountain Capital, commented, “The acquisition of Syntor represents significant progress in New Mountain’s strategic plan for Aceto, as the company continues its track record of growth both organically and through acquisition. The partnership creates significant cross-sell opportunities that benefit customers and supply partners to both businesses.”

Rakesh Sachdev, Chairman of Aceto and Senior Advisor at New Mountain Capital, added, “Syntor brings a portfolio of exciting, proprietary products, developed in-house for many blue-chip customers in the life sciences, pharmaceutical, agrochemical, aroma and electronics industries. We expect Syntor’s product leadership to accelerate as Syntor leverages Aceto’s global partnerships with customers and suppliers.”

Syntor will operate under the name “Syntor by Aceto,” and it is intended that all employees will be retained in their current roles. The combined entity will leverage the increased scale of Syntor and Aceto to provide enhanced value to customers.

Aceto and New Mountain Capital are receiving legal counsel from Freshfields Bruckhaus Deringer, LLP. Ward Hadaway, LLP is serving as legal counsel to Syntor Fine Chemicals.

About Aceto

Founded in 1947, Aceto is a leading global virtual manufacturer supplying niche, differentiated specialty materials in life sciences and advanced technology end markets. With business operations in nine countries, Aceto distributes over 1,100 chemical compounds used principally by the pharmaceutical, nutraceutical, agricultural, and specialty chemical industries. Aceto’s global operations, including a significant staff on the ground in China and India, are distinctive in the industry and enable its worldwide sourcing and regulatory capabilities.www.aceto.com

About Syntor

Founded in 2004 and headquartered in Runcorn, UK, Syntor Fine Chemicals develops and supplies fine chemicals for life sciences and other advanced technology end markets. Syntor uses highly sophisticated synthesis and formulation capabilities in a wide range of synthetic organic transformations. Utilizing multi-purpose, ISO-accredited manufacturing facilities, Syntor provides cost effective, low risk production solutions, from early stage process development through to commercial production. By maintaining an inventory of products in the UK, India and China, Syntor offers short lead times for exports into key markets globally. www.syntor.co.uk

About New Mountain Capital

New Mountain Capital is a New York based investment firm that emphasizes business building and growth, rather than debt, as it pursues long-term capital appreciation. The firm currently manages private equity, public equity, and credit funds with over $20 billion in assets under management. New Mountain seeks out what it believes to be the highest quality growth leaders in carefully selected industry sectors and then works intensively with management to build the value of these companies. For more information on New Mountain Capital, please visit please visit www.newmountaincapital.com.

Media Contact:
Dana Gorman
Abernathy MacGregor
(212) 371-5999
dtg@abmac.com
Show More

A Message Re: Coronavirus (COVID-19) from our CEO

As we are navigating through these unprecedented times, and parsing the ever-changing information regarding, COVID-19, we want to assure you we are actively monitoring the COVID-19 situation and taking steps to support our customers, suppliers, employees and our communities safe.


We have a team dedicated to our response to this pandemic and have business continuity plans to ensure the continuation of services. We are closely monitoring updates from the Centers for Disease Control and the World Health Organization regarding COVID-19. We will continue to seek guidance from these agencies, public health officials and government agencies on an ongoing basis.


Our top priority is the safety and well-being of our customers, suppliers, employees, and communities.


Our Customers & Suppliers


    • As many of you shift to more remote work, we are committed to providing the same level of service you
    have come to expect from Aceto.

     


    • We realize that supply issues may arise in regard to COVID-19. Accordingly, our staff have been working
    to anticipate potential issues to offer supply chain solutions to our customers and suppliers.

Our Employees


 

    • Encouraging our employees to closely monitor their health and well-being.

    • Encouraging our employees to follow the CDC’s suggested hygiene practices to reduce the spread
    of the virus.

    • We are asking our employees to stay home if they, or someone in their household, is sick.

    • Whenever possible we are asking our employees to work remotely.

 


Our Communities


 

Show More

Aceto Names Gilles Cottier as Chief Executive Officer and Rakesh Sachdev as Chairman

Following New Mountain Capital's growth investment into Aceto, life sciences materials veterans going to lead Aceto in its next phase of growth.

Port Washington, NY (USA) - June 20, 2019 - Aceto, a leading virtual manufacturer engaged in the development, marketing and sale of specialty materials serving the life sciences, nutrition, agricultural and advanced technology end markets, announced the appointment of Gilles Cottier as Chief Executive Officer and Rakesh Sachdev as Chairman of the Board of Directors.


“We are pleased to welcome Gilles and Rakesh to Aceto,” said Andre Moura, Managing Director at New Mountain Capital. “Gilles and Rakesh have both demonstrated an exceptional ability to understand customer need and create value for customers, employees and supplier partners within the specialty materials and life sciences industries. We look forward to working closely with Gilles and Rakesh as we invest behind a growth plan to continue Aceto’s success in the markets it serves.”


Mr. Cottier brings more than 30 years of global industry leadership experience in life sciences, fine chemicals, and research chemicals to his new role at Aceto. Most recently, he served as Head of Bioscience at Lonza. Previously, he had held numerous positions of increasing responsibility at Sigma Aldrich during his nearly 30 years there, including his role as Executive Vice President and President of the Sigma Aldrich Fine Chemicals Commercial Unit. Mr. Cottier earned a master’s degree in organic chemistry from the Ecole Supérieure de Chimie Industrielle de Lyon and the advanced management program from the Harvard Business School in Boston.


“I am excited to join Aceto, and I look forward to partnering with Aceto’s long-standing management team and associates to build on Aceto’s impressive growth track record,” said Mr. Cottier. “With its unique market presence, data resources and strong relationships, Aceto is well positioned to continue to invest in building differentiated capabilities and expanding its value proposition to customers and supplier partners.”


Mr. Sachdev recently retired as the CEO of Platform Specialty Products. Previously, he served as President and CEO of Sigma Aldrich, a global life sciences materials and technology company from 2010 to 2015, where he led the organization through its sale to Merck KGaA. Mr. Sachdev earned an M.B.A. from Indiana University, a master’s degree in Engineering from the University of Illinois, and a bachelor’s degree in Mechanical Engineering from the Indian Institute of Technology in New Delhi. He also serves as a Senior Adviser at New Mountain Capital and as a director of Avantor Inc., Element Solutions Inc., Edgewell Personal Care Company, Regal Beloit Corporation, and Washington University in St. Louis.


“Aceto is a leading player in the specialty materials and life science spaces,” said Mr. Sachdev. “Alongside New Mountain, Gilles, and the rest of the management team, I look forward to executing on a strategy to invest in key initiatives and promote accelerated growth going forward. I am thrilled to work once again with Gilles, who, at Sigma Aldrich, consistently demonstrated his outstanding ability to lead and to execute on our strategy in the life sciences and specialty materials spaces.”


About Aceto

Founded in 1947, Aceto is a leading global virtual manufacturer supplying niche, differentiated specialty materials in life sciences and advanced technology end markets. With business operations in nine countries, Aceto distributes over 1,100 chemical compounds used principally by the pharmaceutical, nutraceutical, agricultural, and specialty chemical industries. Aceto’s global operations, including a significant staff on the ground in China and India, are distinctive in the industry and enable its worldwide sourcing and regulatory capabilities.


About New Mountain Capital

New Mountain Capital is a New York based investment firm that emphasizes business building and growth, rather than debt, as it pursues long-term capital appreciation. The firm currently manages private equity, public equity, and credit funds with over $20 billion in assets under management. New Mountain seeks out what it believes to be the highest quality growth leaders in carefully selected industry sectors and then works intensively with management to build the value of these companies. For more information on New Mountain Capital, please visit www.newmountaincapital.com.


Media Contact:
Dana Gorman
Abernathy MacGregor
(212) 371-5999
dtg@abmac.com
Show More